People: Acorda Therapeutics Inc (ACOR.O)
9 Dec 2016
Ms. Lauren M. Sabella is Chief Commercial Officer of Acorda Therapeutics, Inc. Ms. Sabella was the Founder and Principal of Tugboat Consulting Group, an independent consulting practice assisting companies in the commercialization process. Ms. Sabella also served as Corporate Officer and VP of Commercial Development at Altus Pharmaceuticals from May 2006 to September 2008, with responsibility for all aspects of commercialization. Prior to joining Altus, Ms. Sabella was employed by Boehringer Ingelheim Pharmaceuticals for 18 years in positions of increasing responsibility. In her last role, she served as VP of Sales, Eastern Zone, where she led the successful sales launch of Spiriva and ran both Primary Care and Specialty Divisions, including Neurology, Urology and Cardio/Pulmonary. Prior to this role, she had over ten years of marketing experience where she led several brand launches including Mobic, an NSAID which became a $1 billion brand. Ms. Sabella holds a B.B.A. from Hofstra University.
|Total Annual Compensation, USD||446,885|
|Restricted Stock Awards, USD||227,505|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||385,724|
|Fiscal Year Total, USD||1,060,110|